Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta
- PMID: 4031065
- PMCID: PMC423866
- DOI: 10.1172/JCI112012
Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta
Abstract
Type I osteogenesis imperfecta (OI) is characterized clinically by a moderate fracture frequency with minimal bone deformity and dominant inheritance. Previous studies of the collagenous proteins synthesized by dermal fibroblasts obtained from unrelated patients with this form of OI suggested that the biochemical basis of the disease was reduced production of type I collagen. This study was designed to determine if this biochemical finding segregated with the disease within an individual family. Dermal fibroblast strains were established from three generations of a family having the typical features of type I OI. Analysis of the collagenous proteins made in culture revealed an elevated alpha 1(III) to alpha 1(I) collagen type ratio and an elevated alpha 1(I) to alpha 2(I) collagen chain ratio. The procollagen that accumulated in the medium reflected these ratios to the same degree. Total collagen synthesis was significantly reduced in affected family members. Therefore, the most striking abnormality in affected members was a 50-75% reduction of type I collagen production. Furthermore, the ratio of the alpha 1(I)/alpha 2(I) collagen messenger RNA (mRNA), measured by dot hybridization, was one-half of the value of uninvolved family members and unrelated controls. Since the reduction in the production of type I collagen and the altered alpha 1(I)/alpha 2(I) mRNA ratio clearly segregated with affected individuals within this family, these biochemical measurements may be a useful genetic marker for type I OI.
Similar articles
-
Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).Biochim Biophys Acta. 1986 Oct 31;889(1):23-34. doi: 10.1016/0167-4889(86)90005-4. Biochim Biophys Acta. 1986. PMID: 3768427
-
Molecular heterogeneity in osteogenesis imperfecta type I.Am J Med Genet. 1993 Jan 15;45(2):223-7. doi: 10.1002/ajmg.1320450214. Am J Med Genet. 1993. PMID: 8456806
-
Expression of mutant alpha (I)-procollagen in osteoblast and fibroblast cultures from a proband with osteogenesis imperfecta type IV.J Bone Miner Res. 1992 Jul;7(7):793-805. doi: 10.1002/jbmr.5650070709. J Bone Miner Res. 1992. PMID: 1642148
-
The bone cell biology of osteogenesis imperfecta.Connect Tissue Res. 1995;31(4):269-73. doi: 10.3109/03008209509010821. Connect Tissue Res. 1995. PMID: 15612366 Review.
-
Disorders of intracellular protein trafficking in human disease.Connect Tissue Res. 1995;31(4):283-6. doi: 10.3109/03008209509010824. Connect Tissue Res. 1995. PMID: 15612369 Review.
Cited by
-
The incidence of incisional hernia after aortic aneurysm is not higher than after benign colorectal interventions: A retrospective control-matched cohort study.Gefasschirurgie. 2018;23(Suppl 1):23-31. doi: 10.1007/s00772-018-0390-z. Epub 2018 Jun 6. Gefasschirurgie. 2018. PMID: 29950793 Free PMC article. Review.
-
Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.Biochem J. 1989 Jan 15;257(2):439-45. doi: 10.1042/bj2570439. Biochem J. 1989. PMID: 2649075 Free PMC article.
-
Ehlers-Danlos syndrome type IV: cosegregation of the phenotype to a COL3A1 allele of type III procollagen.Hum Genet. 1986 Sep;74(1):41-6. doi: 10.1007/BF00278783. Hum Genet. 1986. PMID: 2875936
-
Absence of mutations in the promoter of the COL1A1 gene of type I collagen in patients with osteogenesis imperfecta type I.J Med Genet. 1995 Sep;32(9):697-700. doi: 10.1136/jmg.32.9.697. J Med Genet. 1995. PMID: 8544188 Free PMC article.
-
Severe osteogenesis imperfecta in cyclophilin B-deficient mice.PLoS Genet. 2009 Dec;5(12):e1000750. doi: 10.1371/journal.pgen.1000750. Epub 2009 Dec 4. PLoS Genet. 2009. PMID: 19997487 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical